Speculative Spotlight: Biocept Is Undervalued Despite Commercial Progress [Seeking Alpha]
Biocept, Inc. (BIOC)
Last biocept, inc. earnings: 3/28 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.biocept.com/investor-relations
Company Research
Source: Seeking Alpha
Summary As the market hits all-time highs, I look for discounted healthcare plays that due for a turnaround. Biocept fits my parameters for a speculative buy despite the downside risks. The company reported strong commercial growth in 2019, but the share price did not follow suit. I discuss the company's current valuation and where it should be priced. I discuss a few downside risks associated with BIOC and how I would like to see the company address these issues. Biocept ( I intend to review the company's commercial progress and defend my position for a speculative buy. In addition, I point out a few downside risks associated with BIOC and how I would like to see the company address these issues. Commercial Progress Back in Q3 The company’s commercial team has improved both test volumes and sales numbers by focusing on precise treatment areas where their liquid biopsy tests have a competitive edge over the competition. In fact, the sales force quarterly numbers per sales rep were up
Show less
Read more
Impact Snapshot
Event Time:
BIOC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIOC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIOC alerts
High impacting Biocept, Inc. news events
Weekly update
A roundup of the hottest topics